Date published: 2025-10-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

Blood Group N antigen Antibody (DRF-8): sc-52374

2.0(1)
Write a reviewAsk a question

Datasheets
  • Blood Group N antigen Antibody (DRF-8) is a mouse monoclonal IgG2b Blood Group N antigen antibody provided at 100 µg/ml
  • raised against N antigen on human cells
  • recommended for detection of Blood Group N antigen of human origin by WB, IP, IF and FCM
  • available conjugated to FITC for IF, IHC(P) and FCM
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for Blood Group N antigen Antibody (DRF-8). This work is in progress.

    QUICK LINKS

    SEE ALSO...

    Blood Group N antigen Antibody (DRF-8) is a mouse monoclonal IgG2b antibody that detects Blood Group N antigen protein of human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and flow cytometry (FCM). Blood Group N antigen (DRF-8) antibody is available in both non-conjugated and various conjugated forms, including fluorescein isothiocyanate (FITC), providing versatility for different experimental needs. Blood Group N antigen (DRF-8) monoclonal antibody recognizes a crucial component of the blood group system, characterized by its role in cell recognition and signaling, which is vital for immune response and cellular interactions. Blood Group N antigen protein is primarily located on the surface of erythrocytes and certain epithelial cells, where Blood Group N antigen (DRF-8) antibody contributes to the structural integrity of the cell membrane and plays a significant role in determining blood compatibility during transfusions. Blood Group N antigen protein is part of a larger family of blood group antigens that can undergo changes during malignant transformation, making Blood Group N antigen (DRF-8) monoclonal antibody an important marker in cancer research. Understanding the expression and modulation of Blood Group N antigen protein can provide insights into tumor biology and the development of targeted therapies.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    Blood Group N antigen Antibody (DRF-8) References:

    1. Blood group N antigen precursor glycoproteins and N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity from human liver metastatic carcinomas.  |  Otsuka, K., et al. 1991. Int J Biochem. 23: 569-78. PMID: 1648519
    2. Two monoclonal antibodies recognizing different epitopes of blood group N antigen.  |  Waśniowska, K., et al. 1988. Arch Immunol Ther Exp (Warsz). 36: 623-32. PMID: 2478103
    3. Radioassays of blood group M, N and T (Thomsen-Friedenreich) antigens.  |  King, MJ. and Holburn, AM. 1979. Immunology. 38: 129-36. PMID: 511213
    4. Biochemistry and Genetics of the ABO, Lewis, and P blood group systems.  |  Watkins, WM. 1980. Adv Hum Genet. 10: 1-136, 379-85. PMID: 6156588
    5. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens.  |  Borén, T., et al. 1993. Science. 262: 1892-5. PMID: 8018146
    6. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity.  |  Appelmelk, BJ., et al. 1996. Infect Immun. 64: 2031-40. PMID: 8675304
    7. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging.  |  Ilver, D., et al. 1998. Science. 279: 373-7. PMID: 9430586

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    Blood Group N antigen Antibody (DRF-8)

    sc-52374
    100 µg/ml
    $316.00

    Blood Group N antigen Antibody (DRF-8) FITC

    sc-52374 FITC
    100 tests in 2 ml
    $330.00